nach oben

Erschienen in:

2016 | OriginalPaper | Buchkapitel

Nanoparticles in Biomedical Applications

verfasst von : Jacqueline Maximilien, Selim Beyazit, Claire Rossi, Karsten Haupt, Bernadette Tse Sum Bui

Erschienen in: Measuring Biological Impacts of Nanomaterials

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Due to readily adaptive sizes, shapes, compositions and large surface area to volume ratios, nanoparticles (NPs) are increasingly prevalent in biomedical applications. In recent times, a plethora of NPs have been investigated specifically regarding how they can be exploited for drug delivery, bioimaging agents and theranostic tools. In this article, lipid-based, inorganic, dendrimeric and polymeric nanoparticles serving these applications are described. The ease of synthesis of these NPs, coupled with an enhanced stability, reduced toxicity and ability to conjugate with diverse molecules (peptides, proteins, antibodies, aptamers) for biocompatibility and biotargeting, indicates that all the key components are being met for their advances towards approved therapies. For their successful applications as drug delivery systems, smart polymeric NPs responding to stimuli such as heat, pH and light to provide controlled release have been introduced. Upconverting nanoparticles and molecularly imprinted polymers, often termed plastic antibodies because of their high affinity and selectivity towards their target molecules, are further discussed as novel bioimaging materials.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Carbon Nanodots: Synthesis, Characterization, and Bioanalytical Applications

Faraji AH, Wipf P (2009) Nanoparticles in cellular drug delivery. Bioorg Med Chem 17(8):2950–2962CrossRef

Gasco MR (1993) Method for producing solid lipid microspheres having a narrow size distribution. US5250236A, USA

Müller RH, Lucks JS (1996) Medication vehicles made of solid lipid nanoparticles (SLN). EP0605497 B1, Germany

Müller RH (2007) Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 59(6):522–530CrossRef

Fang JY et al (2008) Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 70(2):633–640CrossRef

Cavalli R et al (2002) Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 238(1):241–245CrossRef

Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur J Pharm Biopharm 50(1):161–177CrossRef

Almeida AJ, Runge S, Müller RH (1997) Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm 149(2):255–265CrossRef

Almeida AJ, Souto E (2007) Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 59(6):478–490CrossRef

10.

Hu F, Hong Y, Yuan H (2004) Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm 273(1):29–35CrossRef

11.

zur Mühlen A, Schwarz C, Mehnert W (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur J Pharm Biopharm 45(2):149–155

12.

Wissing S, Kayser O, Müller R (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56(9):1257–1272CrossRef

13.

Menger FM, Keiper JS (1998) Chemistry and physics of giant vesicles as biomembrane models. Curr Opin Chem Biol 2(6):726–732CrossRef

14.

Hwang SY et al (2012) Effects of operating parameters on the efficiency of liposomal encapsulation of enzymes. Colloids Surf B Biointerfaces 94:296–303CrossRef

15.

He J et al (2013) Hydrodynamically driven self-assembly of giant vesicles of metal nanoparticles for remote-controlled release. Angew Chem 125(9):2523–2528CrossRef

16.

Apple MA, Hunt CA, Yanagisawa H. (1981) Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same US4263428A, USA

17.

Deamer DW (1985) Method for encapsulating materials into liposomes US4515736 A.

18.

Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13(1):238–252CrossRef

19.

Bangham AD, Hill MW, Miller NGA (1974) Methods in Membrane Biology, Ch 1, Vol 1, Ed. Korn ED, Springer US

20.

Szoka JR, Papahadjopoulos FD (1980) Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng 9(1):467–508CrossRef

21.

Olson F et al (1979) Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta Biomembr 557(1):9–23CrossRef

22.

Szoka F, Papahadjopoulos D (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A 75(9):4194–4198CrossRef

23.

Szoka F et al (1980) Preparation of unilamellar liposomes of intermediate size (0.1–0.2 μm) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta Biomembr 601:559–571

24.

Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4(2):145–160CrossRef

25.

Knudsen NØ et al (2012) Calcipotriol delivery into the skin with PEGylated liposomes. Eur J Pharm Biopharm 81(3):532–539CrossRef

26.

Verma D et al (2003) Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 55(3):271–277CrossRef

27.

Beukelman C et al (2008) Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel^®) for wound healing in vitro. Burns 34(6):845–855CrossRef

28.

Needham D et al (2000) A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res 60(5):1197–1201

29.

Kundu AK et al (2012) Stability of lyophilized siRNA nanosome formulations. Int J Pharm 423(2):525–534CrossRef

30.

Weissig V, Whiteman KR, Torchilin VP (1998) Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm Res 15(10):1552–1556CrossRef

31.

Lurquin PF (1981) Binding of plasmid loaded liposomes to plant protoplasts: validity of biochemical methods to evaluate the transfer of exogenous DNA. Plant Sci Lett 21(1):31–40CrossRef

32.

Torchilin VP, Zhou F, Huang L (1993) pH-sensitive liposomes. J Liposome Res 3(2):201–255CrossRef

33.

Yatvin M et al (1980) pH-sensitive liposomes: possible clinical implications. Science 210(4475):1253–1255CrossRef

34.

Dromi S et al (2007) Pulsed-high intensity focused ultrasound and low temperature–sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res 13(9):2722–2727CrossRef

35.

Gerasimov OV et al (1999) Cytosolic drug delivery using pH-and light-sensitive liposomes. Adv Drug Deliv Rev 38(3):317–338CrossRef

36.

Zalipsky S (1993) Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. Bioconjug Chem 4(4):296–299CrossRef

37.

van der Meel R et al (2014) Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Control Release 195:72–85CrossRef

38.

Patolsky F, Lichtenstein A, Willner I (2000) Amplified microgravimetric quartz-crystal-microbalance assay of DNA using oligonucleotide-functionalized liposomes or biotinylated liposomes. J Am Chem Soc 122(2):418–419CrossRef

39.

Cao Z et al (2009) Reversible cell-specific drug delivery with aptamer-functionalized liposomes. Angew Chem Int Ed 48(35):6494–6498CrossRef

40.

Lehr CM (2000) Lectin-mediated drug delivery: the second generation of bioadhesives. J Control Release 65(1):19–29CrossRef

41.

Allen TM et al (1995) A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta Biomembr 1237(2):99–108CrossRef

42.

FDA (1995) U.S. Doxil^®. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050718s043lbl.pdf

43.

Allen TM, Cullis PR (2013) Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65(1):36–48

44.

Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021CrossRef

45.

Jana NR, Chen Y, Peng X (2004) Size-and shape-controlled magnetic (Cr, Mn, Fe, Co, Ni) oxide nanocrystals via a simple and general approach. Chem Mater 16(20):3931–3935CrossRef

46.

Ruiz JM, Benoit JP (1991) In vivo peptide release from poly (DL-lactic acid-co-glycolic acid) copolymer 5050 microspheres. J Control Release 16(1):177–185CrossRef

47.

Khor E, Lim LY (2003) Implantable applications of chitin and chitosan. Biomaterials 24(13):2339–2349CrossRef

48.

Na HB, Song IC, Hyeon T (2009) Inorganic nanoparticles for MRI contrast agents. Adv Mater 21(21):2133–2148CrossRef

49.

Perez JM, Josephson L, Weissleder R (2004) Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. ChemBioChem 5(3):261–264CrossRef

50.

Chen JF et al (2004) Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 25(4):723–727CrossRef

51.

Arruebo M et al (2007) Magnetic nanoparticles for drug delivery. Nano Today 2(3):22–32CrossRef

52.

Ulman A (1996) Formation and structure of self-assembled monolayers. Chem Rev 96(4):1533–1554CrossRef

53.

Vallet-Regi M et al (2001) A new property of MCM-41drug delivery system. Chem Mater 13(2):308–311CrossRef

54.

Lu Y et al (2002) Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach. Nano Lett 2(3):183–186CrossRef

55.

Liong M et al (2008) Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2(5):889–896CrossRef

56.

Schwenk MH (2010) Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease. Pharmacotherapy 30(1):70–79CrossRef

57.

ClinicalTrials.gov (2015) Using Ferumoxytol-enhanced MRI to measure inflammation in patients with brain tumors or other conditions of the CNS

58.

Dabbousi BO et al (1997) (CdSe) ZnS core-shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. J Phys Chem B 101(46):9463–9475CrossRef

59.

Medintz IL et al (2005) Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 4(6):435–446CrossRef

60.

Gerion D et al (2001) Synthesis and properties of biocompatible water-soluble silica-coated CdSe/ZnS semiconductor quantum dots. J Phys Chem B 105(37):8861–8871CrossRef

61.

Derfus AM, Chan WC, Bhatia SN (2004) Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4(1):11–18CrossRef

62.

Gao X et al (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22(8):969–976CrossRef

63.

Stefani FD, Hoogenboom JP, Barkai E (2009) Beyond quantum jumps: blinking nanoscale light emitters. Phys Today 62(2):34–39CrossRef

64.

Mahler B et al (2008) Towards non-blinking colloidal quantum dots. Nat Mater 7(8):659–664CrossRef

65.

Wang C, Cheng L, Liu Z (2011) Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 32(4):1110–1120CrossRef

66.

Kim J et al (2008) Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv Mater 20(3):478–483CrossRef

67.

Park YI et al (2009) Nonblinking and nonbleaching upconverting nanoparticles as an optical imaging nanoprobe and T1 magnetic resonance imaging contrast agent. Adv Mater 21(44):4467–4471CrossRef

68.

Lee PW et al (2010) Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking. Biomaterials 31:2425–2434CrossRef

69.

Erogbogbo F et al (2010) Biocompatible magnetofluorescent probes: luminescent silicon quantum dots coupled with superparamagnetic iron (III) oxide. ACS Nano 4(9):5131–5138CrossRef

70.

Tomalia DA, Naylor AM, Goddard WA (1990) Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed 29(2):138–175CrossRef

71.

Buhleier E, Wehner W, Vogtle F (1978) Cascade-chain-like and nonskid-chain-like syntheses of molecular cavity topologies. Synthesis 2:155–158CrossRef

72.

Tomalia DA, Fréchet JMJ (2002) Discovery of dendrimers and dendritic polymers: a brief historical perspective. J Polym Sci A Polym Chem 40(16):2719–2728CrossRef

73.

Lee CC et al (2006) A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci U S A 103(45):16649–16654CrossRef

74.

Fischer M, Vögtle F (1999) Dendrimers: from design to application—a progress report. Angew Chem Int Ed 38(7):884–905CrossRef

75.

Haensler J, Szoka FC (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem 4(5):372–379CrossRef

76.

Kojima C et al (2000) Synthesis of polyamidoamine dendrimers having poly (ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem 11(6):910–917CrossRef

77.

Peer D et al (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751–760CrossRef

78.

FDA (2014) Drugs and medical devices search. http://www.fda.gov/

79.

Gebelein CG, Dunn RL (1990) Progress in biomedical polymers. Springer-Verlag New York Inc.

80.

Berscht PC et al (1994) Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics. Biomaterials 15(8):593–600CrossRef

81.

Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release 100(1):5–28CrossRef

82.

Samal SK et al (2012) Cationic polymers and their therapeutic potential. Chem Soc Rev 41(21):7147–7194CrossRef

83.

Huang M, Khor E, Lim LY (2004) Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 21(2):344–353CrossRef

84.

Leong K et al (1998) DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release 53(1):183–193CrossRef

85.

Felt O, Buri P, Gurny R (1998) Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 24(11):979–993CrossRef

86.

Mi FL et al (1999) Chitosan–polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug I effect of phosphorous polyelectrolyte complex and enzymatic hydrolysis of polymer. J Appl Polym Sci 74(7):1868–1879CrossRef

87.

Mi FL et al (1999) Chitosan–polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug II effect of pH-dependent ionic crosslinking or interpolymer complex using tripolyphosphate or polyphosphate as reagent. J Appl Polym Sci 74(5):1093–1107CrossRef

88.

Mi FL et al (1999) Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release. Biomaterials 20(17):1603–1612CrossRef

89.

Mansouri S et al (2006) Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials 27(9):2060–2065CrossRef

90.

Mao HQ et al (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 70(3):399–421CrossRef

91.

Jia Z, Xu W (2001) Synthesis and antibacterial activities of quaternary ammonium salt of chitosan. Carbohydr Res 333(1):1–6CrossRef

92.

Stepnova EA et al (2007) New approach to the quaternization of chitosan and its amphiphilic derivatives. Eur Polym J 43(6):2414–2421CrossRef

93.

Bhattarai N, Gunn J, Zhang M (2010) Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 62(1):83–99CrossRef

94.

Shi XY, Tan TW (2002) Preparation of chitosan/ethylcellulose complex microcapsule and its application in controlled release of Vitamin D₂. Biomaterials 23(23):4469–4473CrossRef

95.

Azzam T et al (2002) Polysaccharide-oligoamine based conjugates for gene delivery. J Med Chem 45(9):1817–1824CrossRef

96.

Hosseinkhani H et al (2004) Dextran–spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection. Gene Ther 11(2):194–203CrossRef

97.

Marchyk N et al (2014) One-pot synthesis of iniferter-bound polystyrene core nanoparticles for the controlled grafting of multilayer shells. Nanoscale 6(5):2872–2878CrossRef

98.

Shastri AP (2003) Non-degradable biocompatible polymers in medicine: past, present and future. Curr Pharm Biotechnol 4(5):331–337CrossRef

99.

FDA (2009) U.S. Implanon™ (etonogestrel implant). http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021529s004lbl.pdf.

100.

de las Heras Alarcón C, Pennadam S, Alexander C (2005) Stimuli responsive polymers for biomedical applications. Chem Soc Rev 34(3):276–285

101.

Fujishige S, Kubota K, Ando I (1989) Phase transition of aqueous solutions of poly (N-isopropylacrylamide) and poly (N-isopropylmethacrylamide). J Phys Chem 93(8):3311–3313CrossRef

102.

Gibson MI, O'Reilly RK (2013) To aggregate, or not to aggregate? considerations in the design and application of polymeric thermally-responsive nanoparticles. Chem Soc Rev 42(17):7204–7213CrossRef

103.

Chun SW, Kim JD (1996) A novel hydrogel-dispersed composite membrane of poly(N-isopropylacrylamide) in a gelatin matrix and its thermally actuated permeation of 4-acetamidophen. J Control Release 38(1):39–47CrossRef

104.

Kidchob T, Kimura S, Imanishi Y (1998) Thermoresponsive release from poly(Glu(OMe))-block-poly(Sar) microcapsules with surface-grafting of poly(N-isopropylacrylamide). J Control Release 50(1–3):205–214CrossRef

105.

Eeckman F, Moës AJ, Amighi K (2002) Evaluation of a new controlled-drug delivery concept based on the use of thermoresponsive polymers. Int J Pharm 241(1):113–125CrossRef

106.

Cooperstein MA, Canavan HE (2013) Assessment of cytotoxicity of (N-isopropyl acrylamide) and Poly (N-isopropyl acrylamide)-coated surfaces. Biointerphases 8(1):19–30CrossRef

107.

Malonne H et al (2005) Preparation of poly(N-isopropylacrylamide) copolymers and preliminary assessment of their acute and subacute toxicity in mice. Eur J Pharm Biopharm 61(3):188–194CrossRef

108.

Schornack PA, Gillies RJ (2003) Contributions of Cell Metabolism and H+ Diffusion to the Acidic pH of Tumors. Neoplasia 5(2):135–145CrossRef

109.

Kyriakides TR et al (2002) pH-sensitive polymers that enhance intracellular drug delivery in vivo. J Control Release 78(1):295–303CrossRef

110.

Dong LC, Hoffman AS (1991) A novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery. J Control Release 15(2):141–152CrossRef

111.

Foss AC et al (2004) Development of acrylic-based copolymers for oral insulin delivery. Eur J Pharm Biopharm 57(2):163–169CrossRef

112.

Panyam J et al (2002) Rapid endo-lysosomal escape of poly (DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16(10):1217–1226CrossRef

113.

Roy D, Cambre JN, Sumerlin BS (2010) Future perspectives and recent advances in stimuli-responsive materials. Prog Polym Sci 35(1):278–301CrossRef

114.

Peng K, Tomatsu I, Kros A (2010) Light controlled protein release from a supramolecular hydrogel. Chem Commun 46(23):4094–4096CrossRef

115.

Patnaik S et al (2007) Photoregulation of drug release in azo-dextran nanogels. Int J Pharm 342(1-2):184–193CrossRef

116.

Alexander C et al (2006) Molecular imprinting science and technology: a survey of the literature for the years up to and including 2003. J Mol Recognit 19(2):106–180CrossRef

117.

Haupt K et al (2012) Molecularly imprinted polymers. In: Molecular imprinting. Springer, pp 1–28

118.

Tse Sum Bui B, Haupt K (2010) Molecularly imprinted polymers: synthetic receptors in bioanalysis. Anal Bioanal Chem 398(6):2481–2492CrossRef

119.

Haupt K (2001) Molecularly imprinted polymers in analytical chemistry. Analyst 126(6):747–756CrossRef

120.

Ton XA et al (2013) A versatile fiber-optic fluorescence sensor based on molecularly imprinted microstructures polymerized in situ. Angew Chem Int Ed 52(32):8317–8321CrossRef

121.

Fuchs Y et al (2013) Holographic molecularly imprinted polymers for label-free chemical sensing. Adv Mater 25(4):566–570CrossRef

122.

Vlatakis G et al (1993) Drug assay using antibody mimics made by molecular imprinting. Nature 361(6413):645–647CrossRef

123.

Ye L, Haupt K (2004) Molecularly imprinted polymers as antibody and receptor mimics for assays, sensors and drug discovery. Anal Bioanal Chem 378(8):1887–1897CrossRef

124.

Hiratani H et al (2005) Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials 26(11):1293–1298CrossRef

125.

Li B et al (2014) Water-compatible silica sol–gel molecularly imprinted polymer as a potential delivery system for the controlled release of salicylic acid. J Mol Recognit 27(9):559–565CrossRef

126.

Hoshino Y et al (2010) Recognition, neutralization, and clearance of target peptides in the bloodstream of living mice by molecularly imprinted polymer nanoparticles: a plastic antibody. J Am Chem Soc 132(19):6644–6645CrossRef

127.

Cutivet A et al (2009) Molecularly imprinted microgels as enzyme inhibitors. J Am Chem Soc 131(41):14699–14702CrossRef

128.

Kunath S et al (2015) Cell and tissue imaging with molecularly imprinted polymers as plastic antibody mimics. Adv Healthcare Mater 4:1322–1326

129.

Tieppo A et al (2012) Sustained in vivo release from imprinted therapeutic contact lenses. J Control Release 157(3):391–397CrossRef

130.

Díaz-García ME, Laínño RB (2005) Molecular imprinting in sol–gel materials: recent developments and applications. Microchim Acta 149(1-2):19–36CrossRef

131.

Beyazit S et al (2014) Versatile synthesis strategy for coating up converting nanoparticles with polymer shells by localized photopolymerization using the particles as internal light sources. Angew Chem Int Ed 53:8919–8923CrossRef

Titel: Nanoparticles in Biomedical Applications
verfasst von: Jacqueline Maximilien
Selim Beyazit
Claire Rossi
Karsten Haupt
Bernadette Tse Sum Bui
Verlag: Springer International Publishing
Buch: Measuring Biological Impacts of Nanomaterials
Print ISBN: 978-3-319-24821-9

Electronic ISBN: 978-3-319-24823-3

Copyright-Jahr: 2016
DOI: https://doi.org/10.1007/11663_2015_12

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht